Hon ANDREW LITTLE (Minister of Health): I thank the member again. In relation to my earlier comments, I said that I'd expect the director-general to be reliant on information provided directly by a pharmaceutical company, as opposed to third-party sources. The information that the Food and Drug Administration considers typically comes directly from pharmaceutical companies, and I therefore think that it is likely, if not probable, that were the director-general to be of a mind to, the director-general could consider data that had been considered and accepted by the Food and Drug Administration in the US, providing that the director-general was satisfied that the information had come from a reliable and credible source. If it comes from a pharmaceutical company, it is the same source that our Pharmac and Medsafe use, so I think it would most likely meet that standard. So I hope that answers that question for the member. 